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used to conttol for cohort (breast feeding may be declining in 
a society overtime), fecundity (older women may breast feed 
longer because they are less likely to become pregnant), or other 
normative aspects of age (it may be considered inappropriate 
for an older woman to breast feed). High-parity women have 
demonstrated high fecundity, and high parity may ~gnal attach-
ment to more traditional values and behaviour. 
The use of modern contraceptives is consistently associated 
with a reduced likelihood of initiating and shorter durations of 
breast feeding. Work by Gomes de Leon and Potter has dem-
onstrated clearly that the timing of initiation of contraception 
and weaning are closely related, either because women think 
that breast feeding and contraceptive use are incompatible, or 
because. they view contraception as a substitute for lactational 
sub-fecundity. Millman has interpreted her analysis of Taiwan-
ese data as providing support for the notion that women substi-
tute contraception for breast feeding to avoid pregnancy. She 
argues further that the physiological effect of oestrogen in oral 
contraceptives on the' quantity of breast milk is not a major 
determinant of weaning. 
ACTIONPLAN 
The World Health Organisation and UNICEF along with 
other organisations committed to the support, protection and 
promotion of breast feeding have appealed to health services 
personnel to establish an environment in health facilities where 
positive breast feeding practices are encouraged. 
Changes in maternity services improve rates of exclusive 
breast feeding in the first weeks of life. Ways to foster breast 
feeding include:-
• Infonning all pregnant women how and why to breast feed. 
• Helping mothers to initiate breast feeding within half hour 
after normal delivery. 
• Allowing rooming-in 24 hours a day. 
• Encouraging breast feeding on demand and 
• Giving the infant no food or drink other than breast milk, 
unless it is medically indicated, until the age of 4 to 6 
months. 
Other measures will, nevertheless, be important to ensure 
that exclusive breast feeding is maintained during the first four 
to six months of life. These measures include:-
• Protecting the right of working women to breast feed. 
Malawi has done very well here by providing three months 
paid maternity leave for all Government employees every 
three years. 
• Continuing to encourage and support breast feeding 
through groups and the health services. 
Health practitioners have an important part to play in 
promoting and supporting exclusive breast feeding. How-
ever Burgess (1977) suggested that "The education of health 
workers, especially doctors, about managing breast feeding 
problems, has been sadly neglected. Sometimes health work-
ers do not practice what they preach, this leads them to be 
less confident to counsel women to breast feed. Health 
workers often set bad examples by bottle feeding their own 
childreq. 
The health and fertility implications of breast feeding pat-
terns in developing countries have received much attention in 
recent years. Prompted in part by the perceived increasing 
popularity of artificial feeding during the 1970s and by re-
ported declines in average durations and proportions of 
women initially breast feeding in several developing countries, 
health organisations such as WHO and UNICEF have placed 
breast feeding promotion high on their health-policy agendas. 
Given the clear health advantages of breast milk for the infant 
and lactation's suppressive effect on fecundity, a decline ill the 
extent of breast feeding is unwelcome news in any country in 
which attempts are made to improve the health of its children 
or for those countries with modest contraceptive use in which 
it is desired to reduce the population growth rate, such as 
Malawi. The time for action is now. 
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Progesterone Only Contraception 
Dr. V. Sangala 
In 1960 the first contraceptive pill became available. By today's 
standards it contained extremely high doses of both estrogen 
and progesterone. It soon became evident that the estrogen 
component of the pill was causing cardiovascular complications 
in some women. 
Research into using progesterone alone as a safer form of 
contraception was intensified. The first progesterone only pill 
was introduced in 1969 and The International Planned Parent-
hood Federation recommended the use of depo-provera as a 
safe, effective contraceptive in 1975. 
Meanwhile the dose of hormones used in the combined piII 
was drastically reduced, which has made the risk pf cardiovas-
cular complications almost disappear. So we/Ie now in the 
fortunate position of having both safe estrogen containing pills, 
together with a variety of safe progesterone only methods. 
The majority of women using hormonal methods of contra-
ception are healthy and fit. However there are a tiny minority 
who are best advised not to use an estrogen containing pill, but 
even these women would be safer using such a method than 
becoming pregnant. 
Progesterone only contraception does not have any of 
the side effects associated with estrogen usage. In particular it 
does not: 
1. Interfere with lactation 
2. Cause an elevation of blood pressure 
3. Change the blood clotting factors 
4. Interfere significantly with liver, carbohydrate, or fat me-
tabolism 
Thus, these methods can safely be used by women with the 
following medical problems, whose disease is not so severe as 
to warrant sterilisation. 
1. High blood pressure, even if this is high enough to require 
medication 
2. A past history of venous thrombosis 
3. Heart disease 
4. Diabetes 
5. Sickle cell disease 
Progesterone alone is often advised for women who develop 
unacceptable estrogen related side effects while on a combined 
pill. These are rare, but the commonest is a rise in blood 
pressure to over 140/90. Many women stop their pills because 
they wrongly attribute a symptom, such as palpitations, head-
ache or fever, to the new pills they are taking. Reassurance is 
what they require, not confirmation of their fears by being told 
to stop the pills. 
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Depo provera is the only method which consistently inhib-
its ovulation. This is achieved by preventing the cyclical 
release of LH and FSH, exactly the same mechaniSm as that 
of the combined oral contraceptive pill (COC). Ovulation is 
sometimes inhibited by the other methods, but this cannot 
be relied upon. 
The other major contraceptive effects of progesterone are its 
local effects on the genital tract. These are: 
1. Making the cervical mucus thick and impenetrable by 
sperm. 
2, Altering tubal function, so that tubal transport of a fertil-
ised ovum is delayed. 
3. Making the endometrium unreceptive so that implanta-
tion does not occur. 
What are the different progesterone only methods of contra-
ception available in Malawi? 
The progesterone only pilI (POP). The POP available here 
is called Ovrette. Its progesterone content is % that of the 
combined pill, Lofeminal. Because the dose is so low it is of 
vital importance that the pills are taken absolutely regularly. 
If a woman is more than 3 hours late with her pill, its efficacy 
is diminished. She should continue with the method, but 
should either abstain from intercourse or make sure her 
partner uses condoms for any act of intercourse within the 
next 48 hours. 
The POP is one of the least effective methods of contracep-
tion because the chance of "user error" in the form of missing 
or being late with pills is so high. It is th-erefore unsuitable for 
adolescents, and for anyone for whom a pregnancy would be 
a disaster. 
Depo-provera. This is an injectable contraceptive containing 
medroxy progesterone acetate which is given in a dose of 150 
milligrams intramuscularly every 3 months. There is thus no 
possibility of "user error". It is important that the injection site 
is not massaged after the injection is given, as this can promote 
too rapid absorption of the hormone. It is the safest, most 
effective contraceptive currently available. 
Norplant. This method should be available here in the near 
future. It is a subdermal implant consisting of 6 silastic capsules, 
each the size of a matchstick, which contain levonorgestrel. The 
hormone is slowly released over a period of at least 5 years, 
which is the major advantage of this method. During the first 
year ovulation is inhibited in about 60% of women. Thereafter, 
as the blood levels decline, ovulatory cycles become more 
frequent. 
The fact that it can be easily removed if pregnancy is desired, 
or if side effects become unacceptable, make it an extremely 
acceptable method. 
Side Effects 
What are the main side effects of progesterone only 
methods? 
The only real problems are menstrual disturbances. 
Women have to be told that their periods may be com-
pletely erratic, and, especially when depo-provera is used, 
they may stop. 40% of women develop amenorrhoea after 
one year of using depo. Although less common, amenor-
rhoea can also occur during use of Norplant or the POP. A 
minority of women have quite heavy irregular bleeding. 
These problems however are acceptable to many women 
once they are reassured. 
Amenorrhoea is beneficial to women's health, as long 
as it is not due to pregnancy. It is often thought of as a 
problem peculiar to the use of depo-provera. In actual fact 
women taking the COC do not experience true periods. They 
bleed only because tablet taking is discontinued for 7 days 
19 
each month. Women who receive depo have no "pill free week", 
therefore it is not surprising that many have no periods. 
Perhaps we should ask the question "Is regular menstruation 
normal"? The answer to this is probably no. Incessant menstrua-
tion is a feature of the "modern world", but this does not make 
it normal. In the past, prolonged periods of breast feeding 
followed by a further pregnancy, meant that women experi-
enced relatively few menstrual periods during their lifetime. 
The abandonment of these breast feeding practices together 
with smaller family size, has meant women are experiencing 
many more menstruations than maybe they were supposed to! 
Incessant ovulation and menstruation are predisposing factors 
for both ovarian and endometrial cancers. The COC and depo-
provera protect against both these cancers. 
Therefore women should be reassured that having no peri-
ods is GOOD news. 
The other problem with depo provera i~ its association with 
a delay in the return of fertility. This is to be expected as it has 
a duration of action of at least 12 weeks, which may be longer 
in some women. However there is absolutely no evidence that 
it causes permanent infertility. The majority of women will 
conceive within 6 months of their last injection, and by 2 years 
there is no difference in fertility between women who have 
received depo and women who have received no method. It is 
important to realise that the commonest cause ofinfertility is a 
sexually transmitted disease. Such diseases are common in 
Malawi, are poorly diagnosed and very poorly treated. By its 
effect on cervical mucus, progesterone'does in fact have some 
protective effect against infection acquired sexually. 
As would be expected, fertility returns rapidly on stopping 
the POP. Women who discontinue Norplant also have a rapid 
return of fertility, 75% of women becoming pregnant within one 
year. 
Contraindications 
Are there any women fOi' whom specific progesterone only 
methods are contraindicated? The POP is not advisable for the 
adolescent, because of its increased "user error" failure rate. 
As the POP does not inhibit ovulation, it will not prevent 
ectopic pregnancy, and is not advised for anyone with such a 
history. It is rarely associated with the formation of painful 
ovarian cysts, and is best avoided by women who have had such 
problems. 
The above do not apply to Depo or Norplant, which can be used 
by any woman who will accept possible menstrual disturbances. 
Women using depo have to understand the possibility of a delay 
in the return of their fertility after their last injection. 
Conclusion 
Progesterone on its own is an effective, safe method of 
hormonal contraception. There are no absolute contraindi-
cations to using depo provera or Norplant, and both can be 
used when an estrogen containing method is contraindi-
cated. A little more care has to be taken with the POP, mainly 
because "user failure" can take place. The main problems 
with all these methods are menstrual irregularities, but many 
women are prepared to accept these once they understand 
they are not dangerous to their health. Amenorrhoea is 
beneficial to women's health, if caused by a contraceptive 
method, and not by its failure. 
Dr. V. Sangala 
Obstetrician 
Kamuzu Central Hospital 
P.O. Box 149 
Lilongwe 
Malawi 
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